TCM Share Price | TCM Stock Screener

TCMLMTD Commodity Chemicals
Share Price BSE
₹49.09
▼ -1.57 (-3.10%)
2026-05-27 00:00:00
As of May 27, 2026, the TCM share price (BSE: TCMLMTD) is ₹49.09, down 3.10% from the previous close, with shares trading between ₹49.00 and ₹51.61, and a 52-week range of ₹37.21–₹74.33. Check TCMLMTD 52-week chart for the annual price range and momentum. Use the TCM stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
TCM Market Cap ₹36.28 Cr.
TCMLMTD P/E Ratio (TTM) -111.24
TCM P/B Ratio 1.36
EPS (TTM) ₹2.31
Dividend Yield -
Debt to Equity 0.19
TCMLMTD 52 Week High ₹74.33
TCM 52 Week Low ₹37.21
Operating Margin -10.00%
Profit Margin -16.67%
TCMLMTD Revenue (TTM) ₹6.00
EBITDA ₹-1.00
Net Income ₹-1.00
Total Assets ₹76.00
Total Equity ₹29.00

TCM Share Price Chart

Screen TCM share price with an interactive chart. Analyse TCMLMTD price trends and volatility across different timeframes.

TCM Company Profile - Fundamental Screener

Screen TCM company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TCMLMTD shares.
Sector Chemicals
Industry Commodity Chemicals
Sub-Sector Commodity Chemicals
Segment E
ISIN INE034F01010

TCM Balance Sheet Screener

Screen TCMLMTD balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019
Assets
Total Assets 76 84 69 61 68 65 69
Current Assets 42 46 10 5 6 5 9
Fixed Assets 14 17 36 55 59 58 58
Liabilities
Total Liabilities 0 0 0 0 0 0 0
Current Liabilities 0 20 20 20 20 20 20
Non-Current Liabilities 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 29 28 30 24 33 33 32
Share Capital 8 8 8 3 3 3 3
Reserves & Surplus 23 21 23 22 29 29 29

TCM Income Statement Screener - Profit & Revenue Analysis

Screen TCM income statement and profit fundamentals. Analyze TCMLMTD quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for TCM share price evaluation.
Item 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Dec 2022-Sept 2022-Jun
Revenue 6 7 3 12 6 7 5 9 11 5 7 5 1 1 1
Expenses 6 7 5 8 7 8 6 9 11 7 8 6 2 2 2
EBITDA -1 0 -2 4 -1 -1 -1 0 1 -2 -1 -1 -1 -1 -1
Operating Profit % -10.00% -14.00% -61.00% 1.00% -10.00% -8.00% -20.00% -8.00% 7.00% -33.00% -10.00% -15.00% -170.00% -46.00% -182.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -1 -1 -2 4 -1 -1 -1 0 1 -2 -1 -1 -1 -1 -1
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit -1 -1 -2 4 -1 -1 -1 -1 1 -2 -1 -1 -1 -1 -1
EPS -1.53 -1.05 -3.00 5.39 -1.16 -0.77 -1.31 -0.48 0.98 -2.21 -0.89 -1.35 -1.72 -0.83 -1.51

TCM Cash Flow Screener - Liquidity Fundamentals

Screen TCMLMTD cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March
Operating Activities -10 2 -11 -4 0 -1 -2
Investing Activities 0 -1 6 4 -1 0 0
Financing Activities 10 -1 5 0 0 -3 5
Net Cash Flow 0 0 0 0 0 -4 4

TCM Shareholding Pattern Screener

See TCM shareholding pattern with promoter, FII, and DII holdings. Check TCM promoter holding and ownership changes for TCMLMTD on TickJournal.
Item 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun
Promoter Holding 49.51% 49.51% 49.51% 49.51% 49.51% 49.51% 49.51% 49.51%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 7.44% 7.44% 7.44% 7.44% 7.44% 7.44% 7.44% 7.44%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 38.35% 38.39% 38.79% 38.77% 38.80% 38.98% 38.61% 38.57%
Other Holding 4.70% 4.66% 4.26% 4.28% 4.25% 4.07% 4.44% 4.48%
Shareholder Count 4,198 4,272 4,564 4,513 4,590 4,680 3,984 3,991

TCM Share Dividend Screener - Share Yield Analysis

Check TCM dividend history with payout and yield data. View TCM dividend details including ex-dates and amounts for TCMLMTD stock.
No dividends declared by TCM.

TCM Stock Index Membership

See which indices include TCM stock. Check TCMLMTD index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
TCM is not part of any tracked indices.
Only major market indices are tracked in our system.

TCM Market Events Screener - Corporate Actions

Get TCM corporate actions including splits, bonuses, and buybacks. Check TCM stock events that may affect TCMLMTD share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA 7.39%
Annual General Meeting NA 5.35%
Annual General Meeting NA -1.29%
2026-05-26 2026-05-26 Quarterly Result Announcement NA -2.14%
2026-02-13 2026-02-13 Quarterly Result Announcement NA 2.25%
2025-11-11 2025-11-11 Quarterly Result Announcement NA 18.24%
2025-08-11 2025-08-11 Quarterly Result Announcement NA 1.66%
2025-05-29 2025-05-29 Quarterly Result Announcement NA -0.05%
2025-02-10 2025-02-10 Quarterly Result Announcement NA -3.67%
2024-11-12 2024-11-12 Quarterly Result Announcement NA 3.11%
2023-11-22 2023-11-22 Extraordinary General Meeting NA -19.35%
2022-07-29 2022-07-29 Extraordinary General Meeting NA 15.39%
2022-04-26 2022-04-27 Rights 6:5 21.40%

TCM Competitors Screener - Peer Comparison

Screen TCMLMTD competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Tata Chemicals 19,112 -11.23 14,584 -3.49% -1,631 52.10
Deepak Fertilisers & Petrochemicals 18,606 19.92 10,355 17.69% 945 71.72
Gujarat Narmada Valley Fert & Chem 7,444 9.49 7,773 -7.39% 753 55.60
Gujarat Alkalies & Chemicals 5,047 -609.83 4,165 6.89% -65 47.96
TANFAC Industries 4,199 60.11 711 27.00% 73 37.49
GHCL 4,093 8.82 3,064 -6.33% 481 34.31
Chemplast Sanmar 3,754 -12.43 4,393 9.61% -110 51.21
Grauer & Weil 3,094 21.11 1,180 7.28% 157 51.24
Thirumalai Chemicals 2,514 -16.66 2,070 -1.54% -46 53.88
Fischer Medical Ventures 2,366 58.20 112 421.86% 1 47.98

TCM Company Announcements - News Screener

Screen TCMLMTD latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-05-25 Board Meeting Intimation for Consideration And Approval Of The Consolidated And Standalone Audited Financial Statements For The Quarter And Year Ended 31St March 2026 -
2026-04-30 Corporate Update-Cancellation Of Order -
2026-04-22 Disclosure/Declaration Under Regulation 31(4) Of SEBI(SAST) Regulations 2011 For The FY Ended 31St March 2026 From The Promoters Of The Company -
2026-04-22 Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A -
2026-04-17 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-03-27 Closure of Trading Window -
2026-02-17 Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday 17Th February 2026 -
2026-02-16 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-13 Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th February 2026 And The Consolidated And Standalone Unaudited Financial Results Along With The Consolidated And Standalone Limited Review Reports For The Quarter Ended 31St December 2025 -
2026-02-03 Board Meeting Intimation for The Consideration And Approval Of The Consolidated And Standalone Financial Results For The Quarter Ended 31St December 2025 -
2026-01-14 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-31 Closure of Trading Window -
2025-11-13 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-11-11 Board Meeting Outcome for And The Consolidated And Standalone Unaudited Financial Results Along With The Consolidated And Standalone Limited Review Reports For The Quarter Ended 30Th September 2025 -
2025-11-10 Intimation Under Regulation 30 Of The SEBI(LODR) Regulations 2015 For Opening Of The Healthcare Division Office Of The Company -
2025-10-29 Board Meeting Intimation for Consideration And Approval Of The Consolidated And Standalone Unaudited Financial Results For The Quarter Ended 30Th September 2025 -
2025-10-14 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-09-30 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2025-09-29 Closure of Trading Window -
2025-09-27 Shareholder Meeting / Postal Ballot-Outcome of AGM -